Meld Valuation / Venture NAV Tracker
FundsCompaniesMethodology
meldvaluation.com ↗

Venture NAV Tracker / Fund

Hercules Capital, Inc. (HTGC)

Filed schedule as of 2026-06-30

Fund website ↗
Structureventure debt BDC
ExchangeNYSE
NAV / share$12.15Jun 30, 2026 · source ↗
Market price$16.36Oct 7, 2026 · source ↗
Premium / discount+34.7%Derived from latest filed NAV per share and market price
Net assets$2.3BJun 30, 2026 · source ↗

Latest observation

NAV vs. market price

Each figure carries its own reporting date.

NAV / share$12.15Jun 30, 2026 · source ↗
Market price$16.36Oct 7, 2026 · source ↗

Fund facts

Manager
Hercules Capital, Inc.
NAV frequency
quarterly
Primary filing
10-Q
Expense ratio
—
Shares outstanding
187,218,000Jun 30, 2026 · source ↗

Cash & equivalents $22.3MJun 30, 2026 · source ↗

Schedule of investments

Debt investments

Jun 30, 2026 reporting period

CompanySecurity typePrincipalCostFair valueFV / principalRateMaturityNon-accrualSource
Marathon Health, LLCHealthcare Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$184.9M$185.8M$184.8M99.9%Prime+0.25% (8.25% floor) · 2.25% PIK · 3.00% exit——Filing ↗
Shield AI, Inc.Defense Technologiessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$148.2M$148.2M$150.2M101.4%Prime+0.85% (6.85% floor) · (9.60% cap) · 2.50% PIK · 2.50% exit——Filing ↗
Dyne Therapeutics, Inc.Drug Discovery & Developmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$142M$141.6M$143.8M101.3%Prime+2.45% (9.95% floor) · 5.50% exit——Filing ↗
Phathom Pharmaceuticals, Inc.Drug Discovery & Developmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$133M$132.2M$133.2M100.2%Prime+3.10% (9.85% floor) · 2.00% exit——Filing ↗
ChenMed, LLCHealthcare Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$130M$128.7M$128.6M98.9%Prime+2.45% (9.45% floor) · 3.75% exit——Filing ↗
Arcus Biosciences, Inc.Drug Discovery & Developmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$76.6M$77.6M$81.1M106.0%Prime - 0.05% (8.45% floor) · 2.20% PIK · 9.00% exit——Filing ↗
Heron Therapeutics, Inc.Drug Discovery & Developmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$80.8M$80.8M$78.5M97.2%Prime+1.95% (9.45% floor) · 1.00% PIK · 6.50% exit——Filing ↗
DocPlannerApplication Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$68.2M$70.2M$77.9M114.3%Prime+2.75% (9.75% floor) · 4.25% exit——Filing ↗
X4 Pharmaceuticals, Inc.Drug Discovery & Developmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$75M$77M$77.2M102.9%Prime+3.15% (10.15% floor) · 3.72% exit——Filing ↗
Saronic Technologies, Inc.Defense Technologiessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$74.4M$73.3M$76.6M102.9%Prime+2.50% (9.00% floor) · 2.00% exit——Filing ↗
Main Street Rural, Inc.Healthcare Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$73.5M$76.1M$76.4M103.9%Prime+1.95% (9.95% floor) · 6.85% exit——Filing ↗
Blue Sprig Pediatrics, Inc.Healthcare Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$77.3M$77.1M$76.3M98.8%1-month SOFR+5.11% (6.00% floor) · 4.45% PIK——Filing ↗
Equality Health, LLCHealthcare Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$72.7M$72.3M$71.5M98.4%Prime+5.85% (9.50% floor) · 1.95% PIK——Filing ↗
Tipalti Solutions Ltd.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$73.3M$73M$71.5M97.5%Prime+0.45% (6.45% floor) · 2.30% PIK——Filing ↗
Locus Robotics Corp.Electronics & Computer Hardwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$65M$65.5M$64.8M99.6%Prime+3.00% (9.50% floor) · 4.00% exit——Filing ↗
AppDirect, Inc.Consumer & Business Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$65.9M$65.5M$64.4M97.8%Prime+2.05% (8.55% floor) · 1.00% PIK · 4.70% exit——Filing ↗
Babel StreetApplication Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$64.8M$64.2M$63.3M97.7%3-month SOFR+8.01% (9.01% floor)——Filing ↗
Curana Health Holdings, LLCHealthcare Servicessecond lienLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Schedule footnote: second lien senior secured debt.$60.8M$61.6M$61.8M101.7%Prime+1.45% (9.20% floor) · 7.45% exit——Filing ↗
Harness, Inc.System Softwaresecond lienLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Schedule footnote: second lien senior secured debt.$59.8M$59.4M$60.3M100.9%Prime - 2.25% (5.25% floor) · (6.50% cap) · 6.25% PIK · 1.00% exit——Filing ↗
Replimune Group, Inc.Drug Discovery & Developmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$57.3M$58.5M$58.3M101.9%Prime+1.75% (8.50% floor) · (9.00% cap) · 1.50% PIK · 4.95% exit——Filing ↗
GoEuro Travel GmbHConsumer & Business Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$58M$58.2M$58M99.9%Prime+3.45% (10.45% floor) · 4.50% exit——Filing ↗
Braeburn, Inc.Drug Discovery & Developmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$53.7M$54.9M$56.2M104.7%Prime+3.00% (10.50% floor) · 0.25% PIK · 5.45% exit——Filing ↗
NeueHealth, Inc.Healthcare Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$55.3M$53.9M$53.6M97.0%Prime+3.65% (12.15% floor) · 2.50% exit——Filing ↗
ReveleerApplication Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$50.6M$52.3M$52.3M103.5%Prime+0.65% (9.15% floor) · 2.00% PIK · 5.05% exit——Filing ↗
MoonLake ImmunotherapeuticsDrug Discovery & Developmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$46M$46.2M$46.9M101.9%Prime+1.45% (8.45% floor) · 6.95% exit——Filing ↗
Smartsheet Inc.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$46.8M$46M$46.8M99.9%3-month SOFR+5.25% (6.00% floor)——Filing ↗
Dashlane, Inc.Application Softwaresecond lienLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Schedule footnote: second lien senior secured debt.$45M$46.2M$46.3M102.9%Prime+3.05% (11.55% floor) · 1.10% PIK · 4.95% exit——Filing ↗
Ennoble Care LLCHealthcare Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$45M$44.9M$45.1M100.2%Prime+2.60% (10.35% floor) · 7.95% exit——Filing ↗
Mango Technologies, Inc.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$45.3M$44.7M$44.5M98.3%Prime+2.25% (8.25% floor) · 2.00% exit——Filing ↗
Marigold Group, Inc.Application Softwaresecond lienLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Schedule footnote: second lien senior secured debt.$45.7M$45.2M$44.1M96.5%3-month SOFR+9.50% (10.50% floor)——Filing ↗
COMPASS Pathways plcDrug Discovery & Developmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$42.5M$42.6M$43.4M102.0%Prime+2.75% (9.75% floor) · 7.75% exit——Filing ↗
Tipalti Solutions Ltd.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$43.2M$43.4M$43.3M100.2%Prime+0.45% (6.45% floor) · 2.30% PIK · 3.75% exit——Filing ↗
Distributed Creation Inc.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$40M$39.8M$39.3M98.4%Prime+3.00% (10.25% floor) · 4.50% exit——Filing ↗
Lexicon Pharmaceuticals, Inc.Drug Discovery & Developmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$39.9M$39.1M$39.1M98.2%Prime+3.10% (9.85% floor) · 6.25% exit——Filing ↗
iSpot.tv, Inc.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$39.3M$39.4M$39M99.4%Prime+1.40% (8.15% floor) · 0.75% PIK · 4.50% exit——Filing ↗
Chainalysis, Inc.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$38.4M$38M$38.7M100.9%Prime+2.95% (10.45% floor)——Filing ↗
Disc Medicine, Inc.Drug Discovery & Developmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$35M$35.2M$36.5M104.2%Prime+1.75% (8.25% floor) · 6.75% exit——Filing ↗
Strive Health Holdings, LLCHealthcare Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$36M$36.1M$36.4M101.2%Prime+1.05% (9.55% floor) · 5.95% exit——Filing ↗
Riviera Partners LLCConsumer & Business Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$35.9M$35.7M$35.5M98.7%3-month SOFR+8.28% (9.28% floor)——Filing ↗
Semperis Technologies Inc.System Softwaresecond lienLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Schedule footnote: second lien senior secured debt.$34.5M$34.1M$34M98.7%Prime - 0.50% (8.00% floor) · 3.85% PIK——Filing ↗
WellBe Senior Medical, LLCHealthcare Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$33.5M$33.9M$33.6M100.2%Prime+0.75% (7.75% floor) · 2.65% PIK · 6.75% exit——Filing ↗
Brain CorporationApplication Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$33.2M$33.5M$33.5M100.6%Prime+1.35% (9.85% floor) · 2.50% PIK · 3.95% exit——Filing ↗
Senseonics Holdings, Inc.Medical Devices & Equipmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$30.6M$31.9M$32.2M105.2%Prime+2.40% (9.90% floor) · 13.40% exit——Filing ↗
Pindrop Security, Inc.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$31M$30.9M$31.7M102.2%Prime+3.50% (10.00% floor) · 2.00% exit——Filing ↗
Loftware, Inc.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$29.5M$29.2M$29.5M100.0%3-month SOFR+7.75% (8.75% floor)——Filing ↗
Sight Sciences, Inc.Medical Devices & Equipmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$28M$28.7M$28.7M102.6%Prime+2.35% (10.35% floor) · 5.95% exit——Filing ↗
uniQure B.V.Drug Discovery & Developmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$27.5M$27.6M$28.5M103.6%Prime+2.45% (9.45% floor) · 5.50% exit——Filing ↗
Gibraltar Acquisition LLCUnsecured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Unsecured loan, as labeled in the June 30, 2026 schedule of investments.$28.8M$28.5M$28.5M98.8%FIXED 11.50%——Filing ↗
Maze Therapeutics, Inc.Drug Discovery & Developmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$28M$27.9M$28.3M101.0%Prime+0.95% (7.95% floor) · 6.45% exit——Filing ↗
Stoke Space Technologies, Inc.Space Technologiessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$28.6M$28.1M$28.2M98.7%Prime+1.00% (7.50% floor) · 2.00% PIK · 5.25% exit——Filing ↗
Sisense Ltd.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$27.7M$29M$28M100.8%Prime+1.50% (9.50% floor) · 1.95% PIK · 5.95% exit——Filing ↗
Carwow LTDConsumer & Business Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$20.8M$28.9M$27.9M134.1%Prime+4.70% (11.45% floor) · 1.45% PIK · 4.95% exit——Filing ↗
PayIt, LLCSystem Softwaresecond lienLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Schedule footnote: second lien senior secured debt.$26.5M$26.6M$26.3M99.2%Prime+1.45% (7.95% floor) · 1.50% PIK · 5.00% exit——Filing ↗
RVShare, LLCConsumer & Business Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$25.8M$25.8M$25.8M99.9%3-month SOFR+9.50% (10.50% floor)——Filing ↗
Remodel Health Holdco, LLCApplication Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$25M$25.3M$25.5M102.0%Prime+2.35% (10.35% floor) · 6.50% exit——Filing ↗
CoreView USA, Inc.System Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$25M$25.2M$25.2M101.0%Prime+2.75% (9.25% floor) · 4.95% exit——Filing ↗
Saama Technologies, LLCInformation Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$24.3M$24.6M$24.8M102.1%Prime+0.70% (8.95% floor) · 2.00% PIK · 3.45% exit——Filing ↗
Semperis Technologies Inc.System Softwaresecond lienLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Schedule footnote: second lien senior secured debt.$24.8M$24.6M$24.6M99.1%Prime+2.50% (9.00% floor) · 1.50% PIK——Filing ↗
Finix Payments, Inc.Consumer & Business Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$24.5M$24.2M$24.2M98.7%Prime+2.50% (9.25% floor) · 4.25% exit——Filing ↗
Aryaka Networks, Inc.Communications & Networkingsecond lienLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Schedule footnote: second lien senior secured debt.$28.5M$29M$23.8M83.6%Prime+1.80% (9.30% floor) · 1.25% PIK · 5.68% exit——Filing ↗
Intercom, Inc.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$22.6M$22.4M$23.8M105.5%Prime+2.00% (8.50% floor) · (9.25% cap) · 1.00% PIK · 3.95% exit——Filing ↗
Semperis Technologies Inc.System Softwaresecond lienLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Schedule footnote: second lien senior secured debt.$23.9M$23.7M$23.7M99.2%Prime - 1.75% (6.75% floor) · 3.25% PIK——Filing ↗
LogRhythm, Inc.System Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$25.2M$24.7M$22.7M90.2%1-month SOFR+7.50% (8.50% floor)——Filing ↗
Sumo Logic, Inc.System Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$23.5M$23.2M$22.7M96.3%3-month SOFR+6.50% (7.50% floor)——Filing ↗
Ceros, Inc.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$22.7M$22.6M$22.3M98.2%3-month SOFR+8.99% (9.89% floor)——Filing ↗
Savara, Inc.Drug Discovery & Developmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$21.5M$21.7M$21.9M102.1%Prime+1.45% (7.45% floor) · 6.95% exit——Filing ↗
Streamline Healthcare SolutionsApplication Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$22.3M$21.7M$21.7M97.6%3-month SOFR+7.30% (8.30% floor)——Filing ↗
Snappt, Inc.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$22M$22M$21.5M97.7%Prime+2.35% (8.85% floor) · 1.00% PIK · 4.25% exit——Filing ↗
New Relic, Inc.System Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$21.9M$21.5M$21.3M97.5%3-month SOFR+6.75% (7.75% floor)——Filing ↗
Funnel Holding AB (publ)Application Softwaresecond lienLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Schedule footnote: second lien senior secured debt.$21.3M$21.1M$21M98.5%Prime+0.60% (7.10% floor) · (8.60% cap) · 3.00% PIK · 2.25% exit——Filing ↗
Elation Health, Inc.Application Softwaresecond lienLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Schedule footnote: second lien senior secured debt.$21.2M$20.9M$20.9M98.6%Prime+1.75% (9.25% floor) · 1.30% PIK · 3.95% exit——Filing ↗
ZeroEyes, Inc.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$21.1M$20.8M$20.5M97.4%Prime+2.00% (9.50% floor) · 2.00% PIK · 1.50% exit——Filing ↗
Earnix, Inc.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$20.5M$20.3M$20.5M100.2%Prime - 1.15% (5.35% floor) · 4.45% PIK——Filing ↗
AlphaSense, Inc.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$20M$19.9M$20.1M100.7%3-month SOFR+6.25% (8.25% floor)——Filing ↗
VulcanForms Inc.Manufacturing Technologysecond lienLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Schedule footnote: second lien senior secured debt.$20M$20.2M$20.1M100.6%Prime+4.25% (11.25% floor) · 4.25% exit——Filing ↗
Weee! Inc.Consumer & Business Productssenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$20M$19.9M$20M100.2%Prime+2.25% (9.75% floor) · 2.50% exit——Filing ↗
Antheia, Inc.Biotechnology Toolssenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$21.3M$20.1M$19.9M93.5%Prime+2.85% (10.35% floor) · 5.55% exit——Filing ↗
Tonal Systems, Inc.Consumer & Business Productssecond lienLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Schedule footnote: second lien senior secured debt.$20M$19.8M$19.8M99.2%Prime+4.25% (11.00% floor) · 4.25% exit——Filing ↗
Alchemer LLCApplication Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$20.1M$19.9M$19.7M98.0%1-month SOFR+8.14% (9.14% floor)——Filing ↗
Peek Travel, Inc.Consumer & Business Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$20M$19.9M$19.5M97.8%Prime+1.75% (9.25% floor) · 1.00% PIK · 4.95% exit——Filing ↗
Modern Life, Inc.Healthcare Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$19M$19.2M$19.1M100.1%Prime+2.75% (10.25% floor) · 5.00% exit——Filing ↗
The Good Health Group, LLCHealthcare Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$19.1M$18.9M$18.9M98.9%Prime+3.45% (10.20% floor) · 5.95% exit——Filing ↗
DevRev, Inc.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$18.8M$18.5M$18.5M98.9%Prime+3.95% (10.70% floor) · (14.70% cap) · 4.25% exit——Filing ↗
Tenpoint Therapeutics LimitedDrug Discovery & Developmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$18.8M$18.7M$18.3M97.5%Prime+2.90% (10.40% floor) · 6.65% exit——Filing ↗
enGene Therapeutics Inc. (p.k.a. enGene, Inc.)Drug Discovery & Developmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$17.5M$17.9M$17.9M102.6%Prime+2.25% (9.25% floor) · (10.25% cap) · 5.95% exit——Filing ↗
Electric Hydrogen Co.Sustainable and Renewable Technologysecond lienLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Schedule footnote: second lien senior secured debt.$17.7M$18M$17.7M100.1%Prime+2.25% (10.75% floor) · 1.25% PIK · 7.45% exit——Filing ↗
Zimperium, Inc.System Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$17.7M$17.6M$17.6M99.5%3-month SOFR+8.10% (9.10% floor)——Filing ↗
Altimmune, Inc.Drug Discovery & Developmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$17.5M$17.6M$17.6M100.7%Prime+2.45% (9.70% floor) · 6.25% exit——Filing ↗
Suzy, Inc.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$22.7M$23M$17M74.9%Prime+1.75% (10.00% floor) · 1.95% PIK · 3.45% exit——Filing ↗
Beren Therapeutics P.B.C.Drug Discovery & Developmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$17.3M$17M$16.8M97.4%Prime+2.45% (9.95% floor) · 5.25% exit——Filing ↗
Perk International Holdings LtdConsumer & Business Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$15.9M$15.6M$15.6M98.1%3-month SOFR+7.00% (9.50% floor)——Filing ↗
Senseonics Holdings, Inc.Medical Devices & Equipmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$15.5M$15.3M$15.4M99.2%Prime+2.40% (9.90% floor) · 6.45% exit——Filing ↗
Orchestra BioMed Holdings, Inc.Medical Devices & Equipmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$15M$15.2M$15.3M102.0%Prime+2.00% (9.50% floor) · 6.35% exit——Filing ↗
4D Molecular Therapeutics, Inc.Drug Discovery & Developmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$15.2M$15M$15M99.0%Prime+2.00% (8.75% floor) · (9.50% cap) · 6.50% exit——Filing ↗
Consensus Intermediate Holdco, LLCHealthcare Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$15M$14.8M$14.8M98.9%Prime+3.20% (9.95% floor) · 3.95% exit——Filing ↗
Proven Optics, LLCApplication Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$15M$14.7M$14.7M97.9%3-month SOFR+7.30% (8.30% floor)——Filing ↗
Scylla DB Ltd.System Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$15M$14.8M$14.6M97.0%Prime+3.00% (10.50% floor) · 0.75% exit——Filing ↗
ProviConsumer & Business Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$14.2M$14.2M$14.1M99.8%Prime+4.40% (10.65% floor) · 3.00% exit——Filing ↗
Nerdy Inc.Consumer & Business Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$14M$14M$14M100.1%Prime+3.50% (10.75% floor) · 7.50% exit——Filing ↗
Hermeus CorporationDefense Technologiessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$14.3M$13.9M$13.9M96.8%Prime+2.75% (10.00% floor) · 1.00% PIK · 4.50% exit——Filing ↗
Ushur, Inc.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$14.2M$14.1M$13.8M97.3%Prime+2.20% (9.20% floor) · 5.95% exit——Filing ↗
Akeyless Security Ltd.System Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$13.4M$13.3M$13.2M98.5%Prime+4.00% (11.00% floor) · 2.95% exit——Filing ↗
Electric Hydrogen Co.Sustainable and Renewable Technologysecond lienLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Schedule footnote: second lien senior secured debt.$12.9M$13M$12.8M99.5%Prime+2.25% (10.75% floor) · 1.25% PIK · 5.75% exit——Filing ↗
Zappi, Inc.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$12.6M$12.4M$12.4M98.8%3-month SOFR+8.03% (9.03% floor)——Filing ↗
Jobandtalent USA, Inc.Consumer & Business Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$14.5M$15.3M$12.3M84.3%1-month SOFR+3.50% (4.50% floor) · 3.25% PIK · 10.47% exit——Filing ↗
Octave Health Group, Inc.Healthcare Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$12.5M$12.3M$12.2M97.4%Prime+2.70% (9.95% floor) · 5.35% exit——Filing ↗
Expel, Inc.System Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$12M$11.9M$11.7M97.7%Prime+3.90% (10.65% floor) · 2.00% exit——Filing ↗
Morphisec Information Security 2014 Ltd.System Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$11.4M$11.8M$11.6M101.5%Prime+3.45% (11.70% floor) · 5.95% exit——Filing ↗
Khoros, LLCApplication Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$11.7M$11.7M$11.3M96.7%FIXED 10.00%——Filing ↗
LinenMaster, LLCApplication Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$11.5M$11.2M$11.1M96.4%1-month SOFR+8.28% (9.28% floor)——Filing ↗
Belong Health, Inc.Healthcare Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$11.3M$11M$10.9M96.6%Prime+2.25% (9.75% floor) · 5.45% exit——Filing ↗
Tarana Wireless, Inc.Communications & Networkingsecond lienLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Schedule footnote: second lien senior secured debt.$11M$10.9M$10.9M98.7%Prime+4.00% (10.75% floor) · 3.95% exit——Filing ↗
Andesa Services, Inc.Consumer & Business Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$11M$10.8M$10.8M97.9%1-month SOFR+7.80% (8.80% floor)——Filing ↗
SynOx Therapeutics LimitedDrug Discovery & Developmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$10.5M$10.5M$10.6M101.0%Prime+1.40% (9.90% floor) · 7.25% exit——Filing ↗
micro1 Inc.Application Softwaresecond lienLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Schedule footnote: second lien senior secured debt.$10.9M$10.6M$10.6M97.5%Prime+3.50% (10.25% floor) · 4.00% exit——Filing ↗
Tungsten Health Holdings, LLCHealthcare Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$10.2M$10.2M$10.2M99.9%Prime+1.00% (8.50% floor) · (9.00% cap) · 1.25% PIK · 8.35% exit——Filing ↗
ControlUp, Inc.System Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$10.1M$10M$10M99.2%Prime+0.25% (6.75% floor) · 2.00% PIK · 3.00% exit——Filing ↗
Neo4j, Inc.System Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$10M$9.9M$9.9M98.8%Prime+2.60% (9.10% floor) · 3.50% exit——Filing ↗
Gibraltar Acquisition LLCUnsecured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Unsecured loan, as labeled in the June 30, 2026 schedule of investments.$10M$9.9M$9.9M98.6%FIXED 11.95%——Filing ↗
CollectiveHealth, Inc.Consumer & Business Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$10.1M$10M$9.8M97.1%Prime+3.50% (10.25% floor) · 3.95% exit——Filing ↗
Loft Orbital Solutions Inc.Space Technologiessecond lienLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Schedule footnote: second lien senior secured debt.$8.9M$8.7M$8.7M98.1%Prime+1.75% (8.75% floor) · 1.00% PIK · 3.45% exit——Filing ↗
Connections Health Holdings, LLCHealthcare Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$8.5M$8.3M$8.3M97.9%Prime+1.20% (7.95% floor) · 1.00% PIK · 6.95% exit——Filing ↗
Tectura CorporationConsumer & Business Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$8.3M$8.3M$8.3M100.0%FIXED 8.25%——Filing ↗
Dispatch Technologies, Inc.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$8.2M$8.1M$8.2M100.0%3-month SOFR+7.86% (8.61% floor)——Filing ↗
Hercules Adviser LLCUnsecured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Unsecured loan, as labeled in the June 30, 2026 schedule of investments.$8M$8M$8M100.0%FIXED 6.75%——Filing ↗
Imagen Technologies, Inc.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$7.5M$7.5M$7.5M99.1%Prime+1.55% (9.05% floor) · 1.00% PIK · 3.95% exit——Filing ↗
Alector, Inc.Drug Discovery & Developmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$7M$7.1M$7.3M104.0%Prime+1.05% (8.05% floor) · 4.75% exit——Filing ↗
Coronet Cyber Security Ltd.System Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$7.4M$7.4M$7.1M95.3%Prime - 2.95% (3.55% floor) · 5.85% PIK——Filing ↗
Omeda Holdings, LLCApplication Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$7M$6.9M$7M99.6%3-month SOFR+8.05% (9.05% floor)——Filing ↗
Skyword, Inc.Consumer & Business Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$6.8M$7.1M$6.9M101.4%Prime+2.75% (9.25% floor) · 1.75% PIK · 5.50% exit——Filing ↗
LeoLabs, Inc.Space Technologiessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$6.6M$6.5M$6.5M98.7%Prime+2.90% (9.65% floor) · 0.95% PIK · 3.50% exit——Filing ↗
Kura Oncology, Inc.Drug Discovery & Developmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$5.5M$5.7M$5.8M106.1%Prime+2.40% (8.65% floor) · 6.05% exit——Filing ↗
DNSFilter, Inc.System Softwaresecond lienLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Schedule footnote: second lien senior secured debt.$5M$5M$5M99.7%Prime+2.15% (8.65% floor) · 0.75% PIK · 4.95% exit——Filing ↗
Renew Home, LLCSustainable and Renewable Technologysecond lienLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Schedule footnote: second lien senior secured debt.$5M$5M$5M99.9%Prime+3.00% (9.25% floor) · 5.00% exit——Filing ↗
Microblink LLCApplication Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$5M$4.9M$4.9M98.2%3-month SOFR+7.84% (8.84% floor)——Filing ↗
Tidal Vision Products, Inc.Sustainable and Renewable Technologysenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$5M$4.8M$4.8M96.1%Prime+2.45% (9.70% floor) · 3.45% exit——Filing ↗
Cognito Therapeutics Group, Inc.Medical Devices & Equipmentsenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$4.5M$4.4M$4.4M96.9%Prime+2.70% (9.95% floor) · 5.75% exit——Filing ↗
Annex CloudApplication Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$3.3M$3.3M$3.3M100.0%PIK Interest 3-month SOFR+9.99% (10.99% floor)—Non-accrualFiling ↗
iSpot.tv, Inc.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$3.3M$3.3M$3.3M99.2%Prime+2.25% (9.00% floor) · 1.00% PIK · 5.70% exit——Filing ↗
Plentific LtdConsumer & Business Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$3M$3.1M$3.2M104.2%Prime+2.55% (11.05% floor) · 2.95% exit——Filing ↗
PayIt, LLCSystem Softwaresecond lienLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Schedule footnote: second lien senior secured debt.$2.8M$2.8M$2.8M99.5%Prime+3.00% (10.25% floor) · 1.50% PIK · 5.00% exit——Filing ↗
Simon Data, Inc.Application Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$5M$5.3M$2.2M43.6%Prime+1.00% (8.75% floor) · 1.95% PIK · 3.59% exit—Non-accrualFiling ↗
Zimperium, Inc.System Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$1.8M$1.8M$1.8M99.2%3-month SOFR+5.39% (6.39% floor)——Filing ↗
Jobandtalent USA, Inc.Consumer & Business Servicessenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$1.1M$1.1M$1.1M100.0%1-month SOFR+1.00% (1.00% floor) · 9.00% PIK——Filing ↗
Annex CloudApplication Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$5.6M$5.6M$00.0%PIK Interest 3-month SOFR+9.99% (10.99% floor)—Non-accrualFiling ↗
Annex CloudApplication Softwaresenior secured loanLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred. — Senior Secured$1.7M$1.7M$00.0%PIK Interest 3-month SOFR+5.73% (6.73% floor)—Non-accrualFiling ↗

Schedule of investments

Warrant & equity positions

Jun 30, 2026 reporting period

CompanyFair value% of NAVSecurityImplied price / shareMethodology / source
Hercules Adviser LLC$40.5MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$40,535,000.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Houzz, Inc.$29.7MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗convertible noteLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.—Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Gibraltar Acquisition LLC$24.4MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$24,421,000.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
SeatGeek, Inc.$6.5MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$4.04Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Arcus Biosciences, Inc.Drug Discovery & Development$6.3MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$30.83Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Alamar Biosciences, Inc.$5.6MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$27.09Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Forbion Growth Opportunities Fund I C.V.$5.2MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.—Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Saronic Technologies, Inc.Defense Technologies$5.1MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$32.79Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Stoke Space Technologies, Inc.Space Technologies$4.4MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$43.92Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Madrigal Pharmaceuticals, Inc.$4.2MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$319.15Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Antheia, Inc.Biotechnology Tools$3.8MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.87Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Dyne Therapeutics, Inc.Drug Discovery & Development$3.8MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$22.21Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Curana Health Holdings, LLCHealthcare Services$3.7MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$3.35Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Shield AI, Inc.Defense Technologies$3.7MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$127.37Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
TG Therapeutics, Inc.$3.4MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$28.98Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
WellBe Senior Medical, LLCHealthcare Services$3.3MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$18.30Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Druva Holdings, Inc.$3.1MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$6.82Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Black Crow AI, Inc. affiliates$3MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$995,000.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Dragos, Inc.$2.7MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$47.79Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Axsome Therapeutics, Inc.$2.7MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$129.71Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Yipit, LLC$2.6MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$64.11Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Maze Therapeutics, Inc.Drug Discovery & Development$2.6MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$29.84Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Stoke Space Technologies, Inc.Space Technologies$2.4MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$53.57Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Nextdoor.com, Inc.$2.3MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$2.27Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
NH Holdings 2025 SPV, L.P.$2.2MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$5.59Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Saronic Technologies, Inc.Defense Technologies$2.2MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$20.05Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Click Therapeutics, Inc.$2.2MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$3.89Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Planet Labs PBC$2MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$33.13Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Whoop, Inc.Fitness Technology$2MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$2.87Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
MoonLake ImmunotherapeuticsDrug Discovery & Development$1.9MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$19.47Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
micro1 Inc.$1.8MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.—Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Stoke Space Technologies, Inc.Space Technologies$1.7MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$59.15Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Valo Health, LLC$1.7MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$3.25Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Phathom Pharmaceuticals, Inc.Drug Discovery & Development$1.6MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$10.85Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Main Street Rural, Inc.Healthcare Services$1.6MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$3,181.45Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
uniQure B.V.Drug Discovery & Development$1.6MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$46.07Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Orchestra BioMed Holdings, Inc.Medical Devices & Equipment$1.6MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$4.31Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Forbion Growth Opportunities Fund II C.V.$1.5MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.—Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Lyft, Inc.$1.5MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$14.61Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Contentful Global, Inc.$1.3MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$11.90Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Verge Analytics, Inc.$1.3MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$6.08Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Saronic Technologies, Inc.Defense Technologies$1.2MJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$17.56Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Strive Health Holdings, LLCHealthcare Services$988KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$12.04Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Carwow LTDConsumer & Business Services$948KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$4.39Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Dashlane, Inc.Application Software$932KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.21Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Valo Health, LLC$899KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$5.29Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Thumbtack, Inc.$827KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$2.41Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Strive Health Holdings, LLCHealthcare Services$809KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$6.25Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Curana Health Holdings, LLCHealthcare Services$790KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.77Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Skydio, Inc.$784KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$3.15Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Tectura Corporation$782KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.24Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Lexicon Pharmaceuticals, Inc.Drug Discovery & Development$725KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.45Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Curevo, Inc.$697KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$7.32Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Hermeus CorporationDefense Technologies$692KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$12.36Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Druva Holdings, Inc.$661KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$7.06Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Skydio, Inc.$655KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.05Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Semperis Technologies Inc.System Software$627KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$3.24Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
NorthSea Therapeutics$623KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$633.77Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Khoros, LLCApplication Software$611KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.—Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Viridian Therapeutics, Inc.Drug Discovery & Development$594KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$18.38Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Harness, Inc.System Software$527KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$2.72Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Kura Oncology, Inc.Drug Discovery & Development$525KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$10.98Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
VulcanForms Inc.Manufacturing Technology$506KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$5.06Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Cloudpay, Inc.$494KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$73.04Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Contentful Global, Inc.$488KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$11.90Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Alamar Biosciences, Inc.$474KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$15.17Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
NorthSea Therapeutics$473KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗convertible noteLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.—Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Pindrop Security, Inc.Application Software$431KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$3.20Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
COMPASS Pathways plcDrug Discovery & Development$429KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$5.69Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Bicycle Therapeutics PLC$416KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$4.24Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Pivot Bio, Inc.Energy Efficiency$405KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.68Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Hypercore Inc.$400KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.72Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Worldremit Group Limited$394KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$40.46Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Belong Health, Inc.Healthcare Services$387KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.20Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Beren Therapeutics P.B.C.Drug Discovery & Development$383KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$2.82Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Locus Robotics Corp.Warehouse Automation$379KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$25.07Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Liberty Zim Co-Invest L.P.$371KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.—Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
HawkEye 360, Inc.Space Technologies$365KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$8.92Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
OfferUp, Inc.$346KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.21Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Mixpanel, Inc.$303KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$3.68Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Bitsight Technologies, Inc.$286KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$9.63Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Orchestra BioMed Holdings, Inc.Medical Devices & Equipment$281KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.67Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Distributed Creation Inc.Application Software$280KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$2.68Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Oportun$276KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$5.71Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Earnix, Inc.Application Software$267KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$12.86Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Octave Health Group, Inc.Healthcare Services$263KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.17Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Curana Health Holdings, LLCHealthcare Services$261KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$4.37Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Fabletics, Inc.$255KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.96Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Bright Machines, Inc.$247KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.63Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
X4 Pharmaceuticals, Inc.Drug Discovery & Development$244KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$4.67Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Loft Orbital Solutions Inc.Space Technologies$240KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$10.58Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Hibercell, Inc.$239KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.07Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
PathAI, Inc.$227KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$4.25Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Imagen Technologies, Inc.Application Software$225KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.72Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Coronado Aesthetics, LLC$222KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.04Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Electric Hydrogen Co.Sustainable and Renewable Technology$219KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.89Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
DroneDeploy, Inc.$210KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$2.19Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Cognito Therapeutics Group, Inc.Medical Devices & Equipment$210KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$2.74Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Sight Sciences, Inc.Medical Devices & Equipment$200KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.77Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Tidal Vision Products, Inc.Sustainable and Renewable Technology$195KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$4.02Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Tipalti Solutions Ltd.Application Software$193KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.38Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Savage X Holding, LLC$190KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.10Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Mango Technologies, Inc.Application Software$188KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$2.64Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Perk Group Inc.$188KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$10.82Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Docker, Inc.$165KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$8.25Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Heron Therapeutics, Inc.Drug Discovery & Development$156KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.43Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
SynOx Therapeutics LimitedDrug Discovery & Development$156KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.28Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
LeoLabs, Inc.$150KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.41Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
micro1 Inc.$147KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$7.88Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Carwow LTDConsumer & Business Services$136KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.78Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Finix Payments, Inc.Consumer & Business Services$136KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.07Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
OfferUp, Inc.$131KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.21Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Elation Health, Inc.Application Software$131KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.21Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Achronix Semiconductor Corporation$122KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.25Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Senseonics Holdings, Inc.Medical Devices & Equipment$122KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.97Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Fulfil Solutions, Inc.$113KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.33Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Akeyless Security Ltd.System Software$105KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.89Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Verge Analytics, Inc.$103KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.—Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
908 Devices, Inc.$101KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$2.06Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Connections Health Holdings, LLCHealthcare Services$99KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.46Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Automation Anywhere, Inc.$97KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.38Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Nerdy Inc.Consumer & Business Services$92KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.92Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Impossible Foods, Inc.$91KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.48Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Modern Life, Inc.Healthcare Services$90KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.42Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Valo Health, LLC$84KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.82Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Cellarity, LLC (p.k.a. Cellarity, Inc.)$83KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.83Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Locus Robotics Corp.Warehouse Automation$81KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$9.53Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
The Recovery Company, Inc. (p.k.a. Recover Together, Inc.)Healthcare Services$80KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.41Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
AppDirect, Inc.Consumer & Business Services$79KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.76Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Vida Health, Inc.Healthcare Services$77KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.40Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Peek Travel, Inc.$74KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.23Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Leapwork ApS$70KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.38Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Savara, Inc.Drug Discovery & Development$68KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$6.12Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Brain CorporationApplication Software$67KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.15Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Senseonics Holdings, Inc.Medical Devices & Equipment$65KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.26Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Phathom Pharmaceuticals, Inc.Drug Discovery & Development$63KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.97Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Morphisec Information Security 2014 Ltd.System Software$63KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.31Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Neo4j, Inc.System Software$62KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$3.37Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Achronix Semiconductor Corporation$59KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.24Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Ushur, Inc.Application Software$56KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.03Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Altumint, Inc.$53KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$31.16Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Fever Labs, Inc.$50KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.14Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Funnel Holding AB (publ)Application Software$44KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.08Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Plentific Ltd$41KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.50Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Tipalti Solutions Ltd.Application Software$38KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.08Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
ZeroEyes, Inc.Application Software$38KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.13Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Tarana Wireless, Inc.Communications & Networking$37KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.04Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Fabletics, Inc.$35KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.81Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Kore.ai, Inc.$35KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.54Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Scylla DB Ltd.System Software$33KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.21Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Cutover, Inc.$32KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.31Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
ControlUp Technologies Ltd.$32KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.52Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
enGene Therapeutics Inc. (p.k.a. enGene, Inc.)Drug Discovery & Development$29KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.40Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Carwow LTDConsumer & Business Services$27KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.25Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
DevRev, Inc.$24KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.15Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Demandbase, Inc.$21KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.03Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Ampion, PBC$20KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.08Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Kura Oncology, Inc.Drug Discovery & Development$19KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.32Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Achronix Semiconductor Corporation$17KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.06Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Redshift Bioanalytics, Inc.$16KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.03Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Grove Collaborative, Inc.$15KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.22Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
CollectiveHealth, Inc.Consumer & Business Services$13KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.02Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
DNAnexus, Inc.$12KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.23Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Leapwork ApS$11KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.12Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Talphera, Inc.$9KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.02Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
X4 Pharmaceuticals, Inc.Drug Discovery & Development$8KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.17Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Worldremit Group Limited$6KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.08Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Sisense Ltd.Application Software$4KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.01Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Skyword, Inc.$4KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Heron Therapeutics, Inc.Drug Discovery & Development$4KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.02Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Rocket Pharmaceuticals, Ltd.$3KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$3.18Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Houzz, Inc.$3KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.01Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Landing Holdings Inc.$3KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.25Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Lendio, Inc.$3KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.02Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Aytu BioScience, Inc.$2KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$2.94Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
PDS Biotechnology CorporationBiotechnology$2KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.80Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Daré Bioscience, Inc.$2KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$1.77Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Veem, Inc.$2KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.02Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Avalo Therapeutics, Inc.Biotechnology$1KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$23.81Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Century Therapeutics, Inc.$1KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.06Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Coronet Cyber Security Ltd.System Software$1KJun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.03Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
CapLinked, Inc.$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Verana Health, Inc.$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Jobandtalent USA, Inc.Consumer & Business Services$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Reischling Press, Inc.$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Rhino Labs, Inc.$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Tectura Corporation$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Tectura Corporation$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
BioQ Pharma Incorporated$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Rafael Holdings, Inc.$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Coronado Aesthetics, LLC$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Modumetal, Inc.$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
SUNation Energy, Inc.$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Lightbend, Inc.$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗equityLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Annex CloudApplication Software$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
First Insight, Inc.$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Simon Data, Inc.Application Software$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Suzy, Inc.Application Software$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
VideoAmp, Inc.$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Aryaka Networks, Inc.Communications & Networking$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Gadget Guard, LLC$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Provi$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Rhino Labs, Inc.$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Skyword, Inc.$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Snagajob.com, Inc.Consumer-related Technologies$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Snagajob.com, Inc.Consumer-related Technologies$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Worldremit Group Limited$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Scynexis, Inc.$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
NetBase Quid, Inc.$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
MacroFab, Inc.$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Tela Bio, Inc.$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
CloudBolt Software, Inc.$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Cloudian, Inc.$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗
Lightbend, Inc.$0Jun 30, 2026 · source ↗—Jun 30, 2026 · source ↗warrantLevel 3 note discloses multiple approaches / cost or transaction-price buckets at asset-class level without identifying this position’s method; no individual method inferred.$0.00Jun 30, 2026 · source ↗10-Q 2026-06-30 ↗

Position history

Reported fair-value marks

Each bar is a disclosed position-quarter.

$17MSuzy, Inc.Jun 30, 2026 · source ↗$71.5MTipalti Solutions Ltd.Jun 30, 2026 · source ↗$43.3MTipalti Solutions Ltd.Jun 30, 2026 · source ↗$13.8MUshur, Inc.Jun 30, 2026 · source ↗$12.4MZappi, Inc.Jun 30, 2026 · source ↗$20.5MZeroEyes, Inc.Jun 30, 2026 · source ↗$19.9MAntheia, Inc.Jun 30, 2026 · source ↗$23.8MAryaka Networks, Inc.Jun 30, 2026 · source ↗$10.9MTarana Wireless, Inc.Jun 30, 2026 · source ↗$19.8MTonal Systems, Inc.Jun 30, 2026 · source ↗$20MWeee! Inc.Jun 30, 2026 · source ↗$10.8MAndesa Services, Inc.Jun 30, 2026 · source ↗$64.4MAppDirect, Inc.Jun 30, 2026 · source ↗$27.9MCarwow LTDJun 30, 2026 · source ↗$9.8MCollectiveHealth, Inc.Jun 30, 2026 · source ↗$24.2MFinix Payments, Inc.Jun 30, 2026 · source ↗$58MGoEuro Travel GmbHJun 30, 2026 · source ↗$29.7MHouzz, Inc.Jun 30, 2026 · source ↗$12.3MJobandtalent USA, Inc.Jun 30, 2026 · source ↗$1.1MJobandtalent USA, Inc.Jun 30, 2026 · source ↗$14MNerdy Inc.Jun 30, 2026 · source ↗$19.5MPeek Travel, Inc.Jun 30, 2026 · source ↗$15.6MPerk International Holdings LtdJun 30, 2026 · source ↗$3.2MPlentific LtdJun 30, 2026 · source ↗$14.1MProviJun 30, 2026 · source ↗$35.5MRiviera Partners LLCJun 30, 2026 · source ↗$25.8MRVShare, LLCJun 30, 2026 · source ↗$6.9MSkyword, Inc.Jun 30, 2026 · source ↗$8.3MTectura CorporationJun 30, 2026 · source ↗$13.9MHermeus CorporationJun 30, 2026 · source ↗$76.6MSaronic Technologies, Inc.Jun 30, 2026 · source ↗$150.2MShield AI, Inc.Jun 30, 2026 · source ↗$28.5MGibraltar Acquisition LLCJun 30, 2026 · source ↗$9.9MGibraltar Acquisition LLCJun 30, 2026 · source ↗$8MHercules Adviser LLCJun 30, 2026 · source ↗$15M4D Molecular Therapeutics, Inc.Jun 30, 2026 · source ↗$7.3MAlector, Inc.Jun 30, 2026 · source ↗$17.6MAltimmune, Inc.Jun 30, 2026 · source ↗$81.1MArcus Biosciences, Inc.Jun 30, 2026 · source ↗$16.8MBeren Therapeutics P.B.C.Jun 30, 2026 · source ↗$56.2MBraeburn, Inc.Jun 30, 2026 · source ↗$43.4MCOMPASS Pathways plcJun 30, 2026 · source ↗$36.5MDisc Medicine, Inc.Jun 30, 2026 · source ↗$143.8MDyne Therapeutics, Inc.Jun 30, 2026 · source ↗$17.9MenGene Therapeutics Inc. (p.k.a. enGene, Inc.)Jun 30, 2026 · source ↗$78.5MHeron Therapeutics, Inc.Jun 30, 2026 · source ↗$5.8MKura Oncology, Inc.Jun 30, 2026 · source ↗$39.1MLexicon Pharmaceuticals, Inc.Jun 30, 2026 · source ↗$28.3MMaze Therapeutics, Inc.Jun 30, 2026 · source ↗$46.9MMoonLake ImmunotherapeuticsJun 30, 2026 · source ↗$473KNorthSea TherapeuticsJun 30, 2026 · source ↗$133.2MPhathom Pharmaceuticals, Inc.Jun 30, 2026 · source ↗$58.3MReplimune Group, Inc.Jun 30, 2026 · source ↗$21.9MSavara, Inc.Jun 30, 2026 · source ↗$10.6MSynOx Therapeutics LimitedJun 30, 2026 · source ↗$18.3MTenpoint Therapeutics LimitedJun 30, 2026 · source ↗$28.5MuniQure B.V.Jun 30, 2026 · source ↗$77.2MX4 Pharmaceuticals, Inc.Jun 30, 2026 · source ↗$64.8MLocus Robotics Corp.Jun 30, 2026 · source ↗$10.9MBelong Health, Inc.Jun 30, 2026 · source ↗$76.3MBlue Sprig Pediatrics, Inc.Jun 30, 2026 · source ↗$128.6MChenMed, LLCJun 30, 2026 · source ↗$8.3MConnections Health Holdings, LLCJun 30, 2026 · source ↗$14.8MConsensus Intermediate Holdco, LLCJun 30, 2026 · source ↗$61.8MCurana Health Holdings, LLCJun 30, 2026 · source ↗$45.1MEnnoble Care LLCJun 30, 2026 · source ↗$71.5MEquality Health, LLCJun 30, 2026 · source ↗$76.4MMain Street Rural, Inc.Jun 30, 2026 · source ↗$184.8MMarathon Health, LLCJun 30, 2026 · source ↗$19.1MModern Life, Inc.Jun 30, 2026 · source ↗$53.6MNeueHealth, Inc.Jun 30, 2026 · source ↗$12.2MOctave Health Group, Inc.Jun 30, 2026 · source ↗$36.4MStrive Health Holdings, LLCJun 30, 2026 · source ↗$18.9MThe Good Health Group, LLCJun 30, 2026 · source ↗$10.2MTungsten Health Holdings, LLCJun 30, 2026 · source ↗$33.6MWellBe Senior Medical, LLCJun 30, 2026 · source ↗$24.8MSaama Technologies, LLCJun 30, 2026 · source ↗$20.1MVulcanForms Inc.Jun 30, 2026 · source ↗$4.4MCognito Therapeutics Group, Inc.Jun 30, 2026 · source ↗$15.3MOrchestra BioMed Holdings, Inc.Jun 30, 2026 · source ↗$32.2MSenseonics Holdings, Inc.Jun 30, 2026 · source ↗$15.4MSenseonics Holdings, Inc.Jun 30, 2026 · source ↗$28.7MSight Sciences, Inc.Jun 30, 2026 · source ↗$6.5MLeoLabs, Inc.Jun 30, 2026 · source ↗$8.7MLoft Orbital Solutions Inc.Jun 30, 2026 · source ↗$28.2MStoke Space Technologies, Inc.Jun 30, 2026 · source ↗$12.8MElectric Hydrogen Co.Jun 30, 2026 · source ↗$17.7MElectric Hydrogen Co.Jun 30, 2026 · source ↗$5MRenew Home, LLCJun 30, 2026 · source ↗$4.8MTidal Vision Products, Inc.Jun 30, 2026 · source ↗$13.2MAkeyless Security Ltd.Jun 30, 2026 · source ↗$10MControlUp, Inc.Jun 30, 2026 · source ↗$25.2MCoreView USA, Inc.Jun 30, 2026 · source ↗$7.1MCoronet Cyber Security Ltd.Jun 30, 2026 · source ↗$5MDNSFilter, Inc.Jun 30, 2026 · source ↗$11.7MExpel, Inc.Jun 30, 2026 · source ↗$60.3MHarness, Inc.Jun 30, 2026 · source ↗$22.7MLogRhythm, Inc.Jun 30, 2026 · source ↗$11.6MMorphisec Information Security 2014 Ltd.Jun 30, 2026 · source ↗$9.9MNeo4j, Inc.Jun 30, 2026 · source ↗$21.3MNew Relic, Inc.Jun 30, 2026 · source ↗$26.3MPayIt, LLCJun 30, 2026 · source ↗$2.8MPayIt, LLCJun 30, 2026 · source ↗$14.6MScylla DB Ltd.Jun 30, 2026 · source ↗$23.7MSemperis Technologies Inc.Jun 30, 2026 · source ↗$34MSemperis Technologies Inc.Jun 30, 2026 · source ↗$24.6MSemperis Technologies Inc.Jun 30, 2026 · source ↗$22.7MSumo Logic, Inc.Jun 30, 2026 · source ↗$17.6MZimperium, Inc.Jun 30, 2026 · source ↗$1.8MZimperium, Inc.Jun 30, 2026 · source ↗$3MBlack Crow AI, Inc. affiliatesJun 30, 2026 · source ↗$0CapLinked, Inc.Jun 30, 2026 · source ↗$12KDNAnexus, Inc.Jun 30, 2026 · source ↗$400KHypercore Inc.Jun 30, 2026 · source ↗$611KKhoros, LLCJun 30, 2026 · source ↗$70KLeapwork ApSJun 30, 2026 · source ↗$1.8Mmicro1 Inc.Jun 30, 2026 · source ↗$2.3MNextdoor.com, Inc.Jun 30, 2026 · source ↗$0Verana Health, Inc.Jun 30, 2026 · source ↗$5.6MAlamar Biosciences, Inc.Jun 30, 2026 · source ↗$35KFabletics, Inc.Jun 30, 2026 · source ↗$255KFabletics, Inc.Jun 30, 2026 · source ↗$15KGrove Collaborative, Inc.Jun 30, 2026 · source ↗$190KSavage X Holding, LLCJun 30, 2026 · source ↗$948KCarwow LTDJun 30, 2026 · source ↗$0Jobandtalent USA, Inc.Jun 30, 2026 · source ↗$1.5MLyft, Inc.Jun 30, 2026 · source ↗$92KNerdy Inc.Jun 30, 2026 · source ↗$346KOfferUp, Inc.Jun 30, 2026 · source ↗$131KOfferUp, Inc.Jun 30, 2026 · source ↗$276KOportunJun 30, 2026 · source ↗$0Reischling Press, Inc.Jun 30, 2026 · source ↗$0Rhino Labs, Inc.Jun 30, 2026 · source ↗$0Tectura CorporationJun 30, 2026 · source ↗$0Tectura CorporationJun 30, 2026 · source ↗$782KTectura CorporationJun 30, 2026 · source ↗$394KWorldremit Group LimitedJun 30, 2026 · source ↗$5.1MSaronic Technologies, Inc.Jun 30, 2026 · source ↗$3.7MShield AI, Inc.Jun 30, 2026 · source ↗$24.4MGibraltar Acquisition LLCJun 30, 2026 · source ↗$40.5MHercules Adviser LLCJun 30, 2026 · source ↗$2KAytu BioScience, Inc.Jun 30, 2026 · source ↗$0BioQ Pharma IncorporatedJun 30, 2026 · source ↗$2KPDS Biotechnology CorporationJun 30, 2026 · source ↗$9KTalphera, Inc.Jun 30, 2026 · source ↗$6.3MArcus Biosciences, Inc.Jun 30, 2026 · source ↗$1KAvalo Therapeutics, Inc.Jun 30, 2026 · source ↗$416KBicycle Therapeutics PLCJun 30, 2026 · source ↗$2KDaré Bioscience, Inc.Jun 30, 2026 · source ↗$3.8MDyne Therapeutics, Inc.Jun 30, 2026 · source ↗$156KHeron Therapeutics, Inc.Jun 30, 2026 · source ↗$239KHibercell, Inc.Jun 30, 2026 · source ↗$525KKura Oncology, Inc.Jun 30, 2026 · source ↗$2.6MMaze Therapeutics, Inc.Jun 30, 2026 · source ↗$1.9MMoonLake ImmunotherapeuticsJun 30, 2026 · source ↗$623KNorthSea TherapeuticsJun 30, 2026 · source ↗$1.6MPhathom Pharmaceuticals, Inc.Jun 30, 2026 · source ↗$0Rafael Holdings, Inc.Jun 30, 2026 · source ↗$3KRocket Pharmaceuticals, Ltd.Jun 30, 2026 · source ↗$68KSavara, Inc.Jun 30, 2026 · source ↗$1.6MuniQure B.V.Jun 30, 2026 · source ↗$1.7MValo Health, LLCJun 30, 2026 · source ↗$899KValo Health, LLCJun 30, 2026 · source ↗$1.3MVerge Analytics, Inc.Jun 30, 2026 · source ↗$103KVerge Analytics, Inc.Jun 30, 2026 · source ↗$594KViridian Therapeutics, Inc.Jun 30, 2026 · source ↗$244KX4 Pharmaceuticals, Inc.Jun 30, 2026 · source ↗$379KLocus Robotics Corp.Jun 30, 2026 · source ↗$784KSkydio, Inc.Jun 30, 2026 · source ↗$2.2MClick Therapeutics, Inc.Jun 30, 2026 · source ↗$3.7MCurana Health Holdings, LLCJun 30, 2026 · source ↗$261KCurana Health Holdings, LLCJun 30, 2026 · source ↗$1.6MMain Street Rural, Inc.Jun 30, 2026 · source ↗$2.2MNH Holdings 2025 SPV, L.P.Jun 30, 2026 · source ↗$988KStrive Health Holdings, LLCJun 30, 2026 · source ↗$3.3MWellBe Senior Medical, LLCJun 30, 2026 · source ↗$2.6MYipit, LLCJun 30, 2026 · source ↗$0Coronado Aesthetics, LLCJun 30, 2026 · source ↗$222KCoronado Aesthetics, LLCJun 30, 2026 · source ↗$1.6MOrchestra BioMed Holdings, Inc.Jun 30, 2026 · source ↗$17KAchronix Semiconductor CorporationJun 30, 2026 · source ↗$122KAchronix Semiconductor CorporationJun 30, 2026 · source ↗$2MPlanet Labs PBCJun 30, 2026 · source ↗$2.4MStoke Space Technologies, Inc.Jun 30, 2026 · source ↗$1.7MStoke Space Technologies, Inc.Jun 30, 2026 · source ↗$91KImpossible Foods, Inc.Jun 30, 2026 · source ↗$0Modumetal, Inc.Jun 30, 2026 · source ↗$405KPivot Bio, Inc.Jun 30, 2026 · source ↗$0SUNation Energy, Inc.Jun 30, 2026 · source ↗$488KContentful Global, Inc.Jun 30, 2026 · source ↗$1.3MContentful Global, Inc.Jun 30, 2026 · source ↗$165KDocker, Inc.Jun 30, 2026 · source ↗$3.1MDruva Holdings, Inc.Jun 30, 2026 · source ↗$661KDruva Holdings, Inc.Jun 30, 2026 · source ↗$0Lightbend, Inc.Jun 30, 2026 · source ↗$0Annex CloudJun 30, 2026 · source ↗$97KAutomation Anywhere, Inc.Jun 30, 2026 · source ↗$286KBitsight Technologies, Inc.Jun 30, 2026 · source ↗$67KBrain CorporationJun 30, 2026 · source ↗$494KCloudpay, Inc.Jun 30, 2026 · source ↗$32KCutover, Inc.Jun 30, 2026 · source ↗$932KDashlane, Inc.Jun 30, 2026 · source ↗$21KDemandbase, Inc.Jun 30, 2026 · source ↗$24KDevRev, Inc.Jun 30, 2026 · source ↗$280KDistributed Creation Inc.Jun 30, 2026 · source ↗$210KDroneDeploy, Inc.Jun 30, 2026 · source ↗$267KEarnix, Inc.Jun 30, 2026 · source ↗$131KElation Health, Inc.Jun 30, 2026 · source ↗$0First Insight, Inc.Jun 30, 2026 · source ↗$113KFulfil Solutions, Inc.Jun 30, 2026 · source ↗$44KFunnel Holding AB (publ)Jun 30, 2026 · source ↗$225KImagen Technologies, Inc.Jun 30, 2026 · source ↗$35KKore.ai, Inc.Jun 30, 2026 · source ↗$11KLeapwork ApSJun 30, 2026 · source ↗$188KMango Technologies, Inc.Jun 30, 2026 · source ↗$147Kmicro1 Inc.Jun 30, 2026 · source ↗$303KMixpanel, Inc.Jun 30, 2026 · source ↗$431KPindrop Security, Inc.Jun 30, 2026 · source ↗$0Simon Data, Inc.Jun 30, 2026 · source ↗$4KSisense Ltd.Jun 30, 2026 · source ↗$0Suzy, Inc.Jun 30, 2026 · source ↗$193KTipalti Solutions Ltd.Jun 30, 2026 · source ↗$38KTipalti Solutions Ltd.Jun 30, 2026 · source ↗$56KUshur, Inc.Jun 30, 2026 · source ↗$0VideoAmp, Inc.Jun 30, 2026 · source ↗$38KZeroEyes, Inc.Jun 30, 2026 · source ↗$474KAlamar Biosciences, Inc.Jun 30, 2026 · source ↗$3.8MAntheia, Inc.Jun 30, 2026 · source ↗$227KPathAI, Inc.Jun 30, 2026 · source ↗$0Aryaka Networks, Inc.Jun 30, 2026 · source ↗$37KTarana Wireless, Inc.Jun 30, 2026 · source ↗$0Gadget Guard, LLCJun 30, 2026 · source ↗$2MWhoop, Inc.Jun 30, 2026 · source ↗$53KAltumint, Inc.Jun 30, 2026 · source ↗$79KAppDirect, Inc.Jun 30, 2026 · source ↗$136KCarwow LTDJun 30, 2026 · source ↗$27KCarwow LTDJun 30, 2026 · source ↗$13KCollectiveHealth, Inc.Jun 30, 2026 · source ↗$136KFinix Payments, Inc.Jun 30, 2026 · source ↗$3KHouzz, Inc.Jun 30, 2026 · source ↗$3KLanding Holdings Inc.Jun 30, 2026 · source ↗$3KLendio, Inc.Jun 30, 2026 · source ↗$74KPeek Travel, Inc.Jun 30, 2026 · source ↗$188KPerk Group Inc.Jun 30, 2026 · source ↗$41KPlentific LtdJun 30, 2026 · source ↗$0ProviJun 30, 2026 · source ↗$0Rhino Labs, Inc.Jun 30, 2026 · source ↗$6.5MSeatGeek, Inc.Jun 30, 2026 · source ↗$4KSkyword, Inc.Jun 30, 2026 · source ↗$0Skyword, Inc.Jun 30, 2026 · source ↗$0Snagajob.com, Inc.Jun 30, 2026 · source ↗$0Snagajob.com, Inc.Jun 30, 2026 · source ↗$827KThumbtack, Inc.Jun 30, 2026 · source ↗$2KVeem, Inc.Jun 30, 2026 · source ↗$6KWorldremit Group LimitedJun 30, 2026 · source ↗$0Worldremit Group LimitedJun 30, 2026 · source ↗$692KHermeus CorporationJun 30, 2026 · source ↗$2.2MSaronic Technologies, Inc.Jun 30, 2026 · source ↗$1.2MSaronic Technologies, Inc.Jun 30, 2026 · source ↗$2.7MAxsome Therapeutics, Inc.Jun 30, 2026 · source ↗$383KBeren Therapeutics P.B.C.Jun 30, 2026 · source ↗$83KCellarity, LLC (p.k.a. Cellarity, Inc.)Jun 30, 2026 · source ↗$1KCentury Therapeutics, Inc.Jun 30, 2026 · source ↗$429KCOMPASS Pathways plcJun 30, 2026 · source ↗$697KCurevo, Inc.Jun 30, 2026 · source ↗$29KenGene Therapeutics Inc. (p.k.a. enGene, Inc.)Jun 30, 2026 · source ↗$4KHeron Therapeutics, Inc.Jun 30, 2026 · source ↗$19KKura Oncology, Inc.Jun 30, 2026 · source ↗$725KLexicon Pharmaceuticals, Inc.Jun 30, 2026 · source ↗$4.2MMadrigal Pharmaceuticals, Inc.Jun 30, 2026 · source ↗$63KPhathom Pharmaceuticals, Inc.Jun 30, 2026 · source ↗$16KRedshift Bioanalytics, Inc.Jun 30, 2026 · source ↗$19.7MAlchemer LLCJun 30, 2026 · source ↗$0Scynexis, Inc.Jun 30, 2026 · source ↗$156KSynOx Therapeutics LimitedJun 30, 2026 · source ↗$3.4MTG Therapeutics, Inc.Jun 30, 2026 · source ↗$84KValo Health, LLCJun 30, 2026 · source ↗$8KX4 Pharmaceuticals, Inc.Jun 30, 2026 · source ↗$20.1MAlphaSense, Inc.Jun 30, 2026 · source ↗$101K908 Devices, Inc.Jun 30, 2026 · source ↗$81KLocus Robotics Corp.Jun 30, 2026 · source ↗$655KSkydio, Inc.Jun 30, 2026 · source ↗$387KBelong Health, Inc.Jun 30, 2026 · source ↗$0Annex CloudJun 30, 2026 · source ↗$99KConnections Health Holdings, LLCJun 30, 2026 · source ↗$790KCurana Health Holdings, LLCJun 30, 2026 · source ↗$90KModern Life, Inc.Jun 30, 2026 · source ↗$263KOctave Health Group, Inc.Jun 30, 2026 · source ↗$809KStrive Health Holdings, LLCJun 30, 2026 · source ↗$3.3MAnnex CloudJun 30, 2026 · source ↗$80KThe Recovery Company, Inc. (p.k.a. Recover Together, Inc.)Jun 30, 2026 · source ↗$77KVida Health, Inc.Jun 30, 2026 · source ↗$0NetBase Quid, Inc.Jun 30, 2026 · source ↗$247KBright Machines, Inc.Jun 30, 2026 · source ↗$0Annex CloudJun 30, 2026 · source ↗$0MacroFab, Inc.Jun 30, 2026 · source ↗$506KVulcanForms Inc.Jun 30, 2026 · source ↗$50KFever Labs, Inc.Jun 30, 2026 · source ↗$210KCognito Therapeutics Group, Inc.Jun 30, 2026 · source ↗$281KOrchestra BioMed Holdings, Inc.Jun 30, 2026 · source ↗$65KSenseonics Holdings, Inc.Jun 30, 2026 · source ↗$122KSenseonics Holdings, Inc.Jun 30, 2026 · source ↗$200KSight Sciences, Inc.Jun 30, 2026 · source ↗$0Tela Bio, Inc.Jun 30, 2026 · source ↗$63.3MBabel StreetJun 30, 2026 · source ↗$59KAchronix Semiconductor CorporationJun 30, 2026 · source ↗$365KHawkEye 360, Inc.Jun 30, 2026 · source ↗$150KLeoLabs, Inc.Jun 30, 2026 · source ↗$240KLoft Orbital Solutions Inc.Jun 30, 2026 · source ↗$33.5MBrain CorporationJun 30, 2026 · source ↗$4.4MStoke Space Technologies, Inc.Jun 30, 2026 · source ↗$20KAmpion, PBCJun 30, 2026 · source ↗$219KElectric Hydrogen Co.Jun 30, 2026 · source ↗$195KTidal Vision Products, Inc.Jun 30, 2026 · source ↗$22.3MCeros, Inc.Jun 30, 2026 · source ↗$105KAkeyless Security Ltd.Jun 30, 2026 · source ↗$0CloudBolt Software, Inc.Jun 30, 2026 · source ↗$0Cloudian, Inc.Jun 30, 2026 · source ↗$32KControlUp Technologies Ltd.Jun 30, 2026 · source ↗$1KCoronet Cyber Security Ltd.Jun 30, 2026 · source ↗$38.7MChainalysis, Inc.Jun 30, 2026 · source ↗$2.7MDragos, Inc.Jun 30, 2026 · source ↗$527KHarness, Inc.Jun 30, 2026 · source ↗$0Lightbend, Inc.Jun 30, 2026 · source ↗$63KMorphisec Information Security 2014 Ltd.Jun 30, 2026 · source ↗$62KNeo4j, Inc.Jun 30, 2026 · source ↗$46.3MDashlane, Inc.Jun 30, 2026 · source ↗$33KScylla DB Ltd.Jun 30, 2026 · source ↗$627KSemperis Technologies Inc.Jun 30, 2026 · source ↗$5.2MForbion Growth Opportunities Fund I C.V.Jun 30, 2026 · source ↗$18.5MDevRev, Inc.Jun 30, 2026 · source ↗$1.5MForbion Growth Opportunities Fund II C.V.Jun 30, 2026 · source ↗$371KLiberty Zim Co-Invest L.P.Jun 30, 2026 · source ↗$8.2MDispatch Technologies, Inc.Jun 30, 2026 · source ↗$39.3MDistributed Creation Inc.Jun 30, 2026 · source ↗$77.9MDocPlannerJun 30, 2026 · source ↗$20.5MEarnix, Inc.Jun 30, 2026 · source ↗$20.9MElation Health, Inc.Jun 30, 2026 · source ↗$21MFunnel Holding AB (publ)Jun 30, 2026 · source ↗$7.5MImagen Technologies, Inc.Jun 30, 2026 · source ↗$23.8MIntercom, Inc.Jun 30, 2026 · source ↗$3.3MiSpot.tv, Inc.Jun 30, 2026 · source ↗$39MiSpot.tv, Inc.Jun 30, 2026 · source ↗$11.3MKhoros, LLCJun 30, 2026 · source ↗$11.1MLinenMaster, LLCJun 30, 2026 · source ↗$29.5MLoftware, Inc.Jun 30, 2026 · source ↗$44.5MMango Technologies, Inc.Jun 30, 2026 · source ↗$44.1MMarigold Group, Inc.Jun 30, 2026 · source ↗$10.6Mmicro1 Inc.Jun 30, 2026 · source ↗$4.9MMicroblink LLCJun 30, 2026 · source ↗$7MOmeda Holdings, LLCJun 30, 2026 · source ↗$31.7MPindrop Security, Inc.Jun 30, 2026 · source ↗$14.7MProven Optics, LLCJun 30, 2026 · source ↗$25.5MRemodel Health Holdco, LLCJun 30, 2026 · source ↗$52.3MReveleerJun 30, 2026 · source ↗$2.2MSimon Data, Inc.Jun 30, 2026 · source ↗$28MSisense Ltd.Jun 30, 2026 · source ↗$46.8MSmartsheet Inc.Jun 30, 2026 · source ↗$21.5MSnappt, Inc.Jun 30, 2026 · source ↗$21.7MStreamline Healthcare SolutionsJun 30, 2026 · source ↗
Figures are compiled from public filings.Read methodologyMELD Valuation